Kymera Therapeutics, Inc.
KYMR
Rankning i aktier
#2180
Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to... Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various immunology-inflammation disorders such as hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, generalized pustular psoriasis, and rheumatoid arthritis. Additionally, Kymera is advancing its IRAKIMiD program, designed to address MYD88-mutated diffuse large B cell lymphoma. Other key programs include the STAT3 program, focused on hematological malignancies, solid tumors, autoimmune diseases, and fibrosis, as well as the MDM2 program, which is also aimed at hematological malignancies and solid tumors. The company was founded in 2015 and maintains its headquarters in Watertown, Massachusetts.
Aktiekurs
$114.06
Senast synkroniserad: 2026-10-20
Marknadsvärde
$9.38B
Förändring (1 dag)
5.54%
Förändring (1 år)
95.57%
Land
US
Handel Kymera Therapeutics, Inc. (KYMR)
Kategori
Healthcare
P/B-tal för Kymera Therapeutics, Inc. (KYMR)
P/B-tal per October 2026 TTM: 6.95
Enligt Kymera Therapeutics, Inc. senaste finansiella rapporter och aktiekurs är det aktuella P/B-talet (TTM) 6.95. I slutet av 2023 hade företaget ett P/B-tal på 3.76.
Historik för P/B-tal för Kymera Therapeutics, Inc. från 2018 till 2026
P/B-tal vid årets slut
| År | P/B-tal | Ändra |
|---|---|---|
| 2026 (TTM) | 6.95 | 92.50% |
| 2024 | 3.61 | -3.97% |
| 2023 | 3.76 | 36.99% |
| 2022 | 2.75 | -58.57% |
| 2021 | 6.63 | -31.88% |
| 2020 | 9.73 | -148.89% |
| 2019 | -19.91 | -53.72% |
| 2018 | -43.01 | 0.00% |
P/B-tal för liknande företag eller konkurrenter
| Företag | P/B-tal | Skillnad i P/B-tal | Land |
|---|---|---|---|
| 6.251 | -10.05% |
US
|
|
| 13.2547 | 90.73% |
US
|
|
| 4.208 | -39.45% |
AU
|
|
| - | - |
CH
|
|
| 6.1824 | -11.04% |
NL
|
